BakS eSports vs G2 Ares

This market refers to the Counter-Strike match between BakS eSports and G2 Ares in the CCT Europe Series #11 Group Stage, initially scheduled for October 16, 2026 UTC.
This market will resolve to "BakS eSports" if BakS eSports win the match against G2 Ares.
This market will resolve to "G2 Ares" if G2 Ares win the match against BakS eSports.
If the match is canceled (not played at all) or ends in a tie, this market will resolve to 50-50.
If the match is postponed, it must be rescheduled to a start time on or before October 30, 2026, 23:59 UTC (14 calendar days after the originally scheduled start of October 16, 2026 UTC). If, by that deadline, the most recently announced rescheduled start time is on or before the deadline, this market resolves based on the result of the match as played. Otherwise, this market resolves 50-50, regardless of whether the match is subsequently played.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
In cases where a team’s listed name includes minor discrepancies from the resolution source, or the team is renamed or rebranded, this market will resolve based on the underlying real-world match rather than exact name matching.
Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition.
If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.